2026 NPPES data Rheumatology Physician NPI 1770627713 DO
Verify on CMS →

TATYANA GRINCHENKO, DO

Rheumatology Physician in WAYNE, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 233 beneficiaries · Rheumatology Physician avg: 2K
Generic prescribing
66%
generic claims · 34% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$1.7K
92 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: TATYANA GRINCHENKO, DO is a Rheumatology Physician ([object Object]) practicing in WAYNE, New Jersey with a Medicare Part D prescribing footprint of 1K claims across 233 beneficiaries — 34% brand-name prescribing . Their CMS MIPS Final Score of 75/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $1.7K across 92 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: TATYANA GRINCHENKO, DO reported a CMS MIPS final score of 75 out of 100, below the 83.1 national average, and filed 1,427 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

TATYANA GRINCHENKO, DO practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

TATYANA GRINCHENKO, DO at a glance

Below national average

NPI registry status

Active

Issued 02/15/2007

NPI 1770627713

Primary specialty

Rheumatology Physician

Mid-sized

6,181 US NPIs in this specialty

Medicare Part D claims

1,427 31% vs specialty avg

2023 prescription claims

Specialty avg: 2,054

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New Jersey

How Rheumatology Physician compares to other specialties among New Jersey providers

New Jersey providers

Rheumatology Physician share within New Jersey

1. Rheumatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Rheumatology Physician share within New Jersey

Medicare quality performance — MIPS

TATYANA GRINCHENKO, DO's 2023 MIPS final score plotted against the Rheumatology Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Rheumatology Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Rheumatology Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

TATYANA GRINCHENKO, DO is a Rheumatology Physician provider practicing in WAYNE, New Jersey, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: DO. NPI: 1770627713. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

TATYANA GRINCHENKO, DO appears in the CMS NPPES registry as a Rheumatology Physician provider holding DO credentials at 506 HAMBURG TPKE STE 201, WAYNE, NJ, 07470, with a listed phone of (201) 282-8356. NPI 1770627713 was issued on 02/15/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GRINCHENKO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,427 prescription claims written by this provider, covering 233 Medicare beneficiaries and totaling roughly $2.7 million in drug spend, split 34% brand-name and 66% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Rheumatology Physician is a mid-sized specialty nationwide, with 6,181 enrolled providers across 52 states and an average of 2,054 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

506 HAMBURG TPKE STE 201
WAYNE, NJ 07470

Provider Details

NPI 1770627713
Specialty Rheumatology Physician
Credentials DO
Gender Female
NPI Issued 02/15/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for TATYANA GRINCHENKO, DO. Source: openpaymentsdata.cms.gov.

Total received

$1.7K

Largest payer

Amgen Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

TATYANA GRINCHENKO, DO — brand share 34.0%
Specialty average (est.)

34% brand-name claims vs 66% generic, on 1,427 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,427
Total Claims
$2.7M
Total Drug Cost
233
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,177
Total Day Supply
94,039
Brand vs Generic
34% brand / 66% generic
Brand Drug Cost
$2.6M
Generic Drug Cost
$79K

Patient Demographics

Average Patient Age
72.8 years
Avg HCC Risk Score
1.59
Gender Split
88% female / 12% male
Age Distribution
<65: 32, 65-74: 94, 75-84: 79, 85+: 28

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Hydroxychloroquine Sulfate
174
Methotrexate
Methotrexate Sodium
166
Prolia
Denosumab
101
Prednisone
76
Diclofenac Sodium
62
Enbrel Sureclick
Etanercept
55
Cimzia
Certolizumab Pegol
54
Evenity (2 Syringes)
Romosozumab-Aqqg
47
Humira(Cf) Pen
Adalimumab
46
Otezla
Apremilast
42

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Rheumatology Physician Overview

How TATYANA GRINCHENKO, DO fits within the Rheumatology Physician landscape nationally.

6,181
Rheumatology Physician Providers in US
52
States with Rheumatology Physician
2,054
Avg Claims per Provider

TATYANA GRINCHENKO, DO's 1,427 claims are below the specialty average of 2,054.

Nearby Rheumatology Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as GRINCHENKO.

Compare Rheumatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is TATYANA GRINCHENKO, DO's specialty?
TATYANA GRINCHENKO, DO specializes in Rheumatology Physician and practices in WAYNE, New Jersey. Credentials: DO.
How much does TATYANA GRINCHENKO, DO prescribe under Medicare Part D?
In 2023, TATYANA GRINCHENKO, DO wrote 1,427 Medicare Part D claims totaling $2.7M in drug costs for 233 beneficiaries.
What is TATYANA GRINCHENKO, DO's Medicare quality score?
TATYANA GRINCHENKO, DO has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is TATYANA GRINCHENKO, DO located?
TATYANA GRINCHENKO, DO is located at 506 HAMBURG TPKE STE 201, WAYNE, NJ, 07470. Phone: (201) 282-8356.
What is TATYANA GRINCHENKO, DO's NPI number?
TATYANA GRINCHENKO, DO's National Provider Identifier (NPI) is 1770627713, issued on 02/15/2007.
Does TATYANA GRINCHENKO, DO prescribe more brand-name or generic drugs?
TATYANA GRINCHENKO, DO's prescribing is 34% brand-name and 66% generic drugs by claim count, with $2.6M in brand drug costs.
How many Rheumatology Physician providers are there in the US?
There are 6,181 Rheumatology Physician providers across 52 states in the US. The average Rheumatology Physician provider writes 2,054 Medicare Part D claims per year.
What drugs does TATYANA GRINCHENKO, DO prescribe most often?
Based on 2023 Medicare Part D data, TATYANA GRINCHENKO, DO's most frequently prescribed drugs include Hydroxychloroquine Sulfate, Methotrexate, Prolia. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does TATYANA GRINCHENKO, DO accept Medicare?
TATYANA GRINCHENKO, DO appears in CMS Medicare data with 1,427 Part D claims and 233 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify TATYANA GRINCHENKO, DO's credentials?
TATYANA GRINCHENKO, DO's NPI is 1770627713 with credentials DO. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology